When Your Patients Can't Find Their Prempro Prescription

You write the prescription. Your patient goes to the pharmacy. The pharmacy says Prempro 0.625/5 28 Day is out of stock. Now the patient is calling your office — frustrated, symptomatic, and unsure what to do next.

This scenario has become increasingly common. Prempro 0.625/5 mg, the highest-strength formulation of this combination HRT product, faces recurring availability challenges due to single-manufacturer supply, no generic competition, and pharmacy stocking decisions that deprioritize low-turnover products.

This guide provides actionable steps your practice can take to help patients navigate these supply challenges and maintain continuity of hormone replacement therapy.

Current Availability of Prempro 0.625/5 28 Day

As of 2026, Prempro 0.625/5 mg is:

• Manufactured exclusively by Pfizer — no other suppliers
• Not available as a generic — no AB-rated alternative exists
• Inconsistently stocked — large chain pharmacies frequently don't carry the 0.625/5 strength due to low local demand
• Available at the wholesaler level in most cases — the issue is typically pharmacy-level stocking, not a true national shortage

The cash price ranges from $250 to $450 per 28-day pack, adding a cost barrier for patients whose pharmacies need to special-order the product.

Why Patients Can't Find It

Understanding the root causes helps you advise patients more effectively:

Pharmacy Formulary and Stocking Algorithms

Large chain pharmacies use automated inventory systems that order based on recent dispensing history. If a location hasn't filled a Prempro 0.625/5 prescription recently, the system may not maintain stock. The medication essentially disappears from the pharmacy's active inventory — even though it's available from wholesalers.

Single-Source Vulnerability

With Pfizer as the sole manufacturer and no generic competition, any production variability — quality holds, maintenance shutdowns, raw material delays — directly impacts national availability. There's no secondary supplier to absorb demand.

Strength-Specific Issues

Prempro 0.625/5 is the highest and least commonly prescribed strength. Lower doses (0.3/1.5, 0.45/1.5, 0.625/2.5) tend to be more consistently available. This strength-specific scarcity means a patient on the highest dose faces the most difficulty.

What Providers Can Do: 5 Actionable Steps

Step 1: Direct Patients to Medfinder

Medfinder is a real-time availability search tool designed for hard-to-find medications. Patients can search by medication name and zip code to find pharmacies that currently have Prempro 0.625/5 in stock.

Consider incorporating Medfinder into your practice workflow:

• Include the link (medfinder.com/providers) in patient discharge instructions or after-visit summaries
• Have front desk or nursing staff share the resource with patients receiving HRT prescriptions
• Use the provider tools for quick pharmacy lookups during the visit

Step 2: Prescribe Component Medications as a Backup

Prempro combines conjugated estrogens (Premarin) and medroxyprogesterone acetate (Provera) into one tablet. When the combination product is unavailable, prescribing these as two separate medications provides the same active ingredients:

• Premarin 0.625 mg — one tablet daily
• Medroxyprogesterone Acetate 5 mg (generic available) — one tablet daily

Generic medroxyprogesterone is widely available and costs under $15/month. Premarin remains brand-name only but is typically more available than the Prempro combination product.

Step 3: Evaluate Dose Reduction

For patients currently on the 0.625/5 mg strength, consider whether a lower dose would maintain adequate symptom control. Current guidelines from NAMS recommend using the lowest effective dose for the shortest duration:

• Prempro 0.625/2.5 mg is more widely stocked and may be sufficient for many patients
• Stepping down from 5 mg to 2.5 mg of medroxyprogesterone still provides endometrial protection
• Dose reduction may also improve the patient's cardiovascular and breast cancer risk profile

Step 4: Have Therapeutic Alternatives Ready

Document approved alternatives in the patient's chart so switches can be executed quickly when Prempro is unavailable:

• Activella 1/0.5 mg or generic estradiol/norethindrone acetate — continuous combined oral HRT; generic widely available at $20–$50/month
• Bijuva (1 mg estradiol / 100 mg progesterone) — bio-identical combination capsule, taken at bedtime
• CombiPatch 0.05/0.14 mg — combination transdermal patch, applied twice weekly; advantageous for patients with hepatic concerns or VTE risk factors

Pre-authorizing a specific alternative in the chart allows your office to generate a new prescription quickly when a patient calls about a fill failure.

Step 5: Recommend Independent and Mail-Order Pharmacies

Advise patients that independent pharmacies often have greater flexibility in medication sourcing. These pharmacies may:

• Use multiple wholesalers, increasing the chance of locating Prempro
• Be willing to place special orders for individual patients
• Maintain stock for patients with recurring prescriptions

Mail-order pharmacies — including those offered through insurance plans — typically draw from larger distribution centers and may have better availability.

Alternative Medications: Quick Reference

For a detailed comparison, see our clinical breakdown in Prempro shortage: what prescribers need to know. Summary table:

• Activella / generic — Oral tablet, estradiol 1 mg + norethindrone 0.5 mg. Generic available. Good general alternative.
• Bijuva — Oral capsule, estradiol 1 mg + progesterone 100 mg. Bio-identical. Brand only.
• CombiPatch — Transdermal patch, estradiol 0.05 mg/day + norethindrone 0.14 or 0.25 mg/day. Twice-weekly application.
• Premarin + generic MPA — Separate tablets. Same ingredients as Prempro. Easier to source individually.

Workflow Tips for Your Practice

• Flag Prempro patients in your EHR: Create a registry or flag for patients on Prempro so your team can proactively reach out about alternatives if a widespread supply disruption occurs
• Template your alternatives: Build a prescription template or SmartPhrase for your preferred Prempro alternatives to save time
• Educate patients proactively: During routine visits, discuss the availability situation and establish a backup plan before the patient encounters a fill failure
• Track availability patterns: If your practice serves many HRT patients, consider having a staff member monitor Medfinder periodically for regional availability trends

Final Thoughts

The Prempro 0.625/5 28 Day availability challenge is a practical problem with practical solutions. By integrating tools like Medfinder into your workflow, maintaining documented alternative prescribing plans, and educating patients proactively, your practice can minimize the impact of supply disruptions on patient care.

Menopausal hormone therapy is not optional for many patients — it's essential for quality of life, bone health, and daily functioning. A few minutes of advance planning can prevent weeks of treatment disruption.

For more clinical context, read Prempro 0.625/5 shortage: what prescribers need to know in 2026.